Skip to main content
. 2019 Aug 1;7:e7431. doi: 10.7717/peerj.7431

Figure 3. Correlation between the expression level of ARHGAP10 and relapse free survival (RFS) and the responses to the chemotherapeutic agents.

Figure 3

(A) The prognostic value of ARHGAP10 about RFS assessed by Kaplan Meier Plotter which contains 3955 cases divided by the median expression of ARHGAP10. HR = 0.84 (0.75–0.94), p = 0.0015. (B) The expression of ARHGAP10 in different drug response groups analyzed by GEO2R with GSE45898.